Skip to main content
OpenTrials
Completed

NCT Number: NCT01647581

Risk of Post-polypectomy Bleeding With Prophylactic Hemoclipping

A randomized trial aimed at determining whether or not hemoclips are effective in preventing post-polypectomy bleeds on polyps that are 10mm in size or greater.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Post-polypectomy Bleeding Elective Colonoscopy Polypectomy

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients presenting for elective colonoscopy

Exclusion criteria

  • Patients in which polypectomy can not be performed safely

Treatment and study plan

Hemoclip Placement

Device

Placement of hemoclip at polypectomy site for polyps at least 1cm in size

Other names: Clip

NO hemoclip placement

Device

No hemoclip placement (placebo / sham)

Other names: No Clip

Primary outcomes

  1. Number of Patients With Delayed Post Polypectomy Bleeding

    Time frame: 30 days

    rectal bleeding with associated Hb 2g drop, hemodynamic instability, or need for repeat colonoscopy or angiography or surgery

Sponsors and collaborators

Lead sponsor

VA Office of Research and Development

Fed

Registry information

Important dates

Study start
2011
Primary completion
2018
Study completion
2018
First posted
Jul 23, 2012
Registry last updated
Oct 15, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.